Skip to main content
. 2009 Apr 14;94(7):2558–2564. doi: 10.1210/jc.2008-2278

Table 1.

Participant characteristics (n = 2490)

African-Americans (n = 1293) Non-Hispanic whites (n = 1197) P value
Age, yra 63.6 ± 9.3 58.9 ± 10.2 <0.001
Men, n (%)a 373 (28.9) 510 (42.6) <0.001
BMI, kg/m² 31.6 ± 6.6 30.8 ± 6.3 0.47
Waist circumference, cm 103.6 ± 14.5 100.6 ± 15.9 0.83
Plasma glucose, mg/dl 112.7 ± 47.7 104.9 ± 24.5 <0.001
Plasma insulin, IU/ml 9.3 ± 8.2 8.0 ± 6.0 0.005
HOMA-IR 3.4 ± 10.4 2.3 ± 2.7 0.011
Diabetes, n (%) 385 (29.8) 177 (14.8) <0.001
Total cholesterol, mg/dl 201.7 ± 41 197.3 ± 34.8 0.004
HDL cholesterol, mg/dl 57.7 ± 18.3 51.9 ± 15.3 <0.001
Triglycerides, mg/dl 101.5 (77.5–142) 135 (97–192) <0.001
Hypertension 1034 (80) 875 (73) <0.001
Systolic BP, mm Hg 138.6 ± 20.9 131.1 ± 17.1 <0.001
Diastolic BP, mm Hg 79 ± 10.8 73.8 ± 9.3 <0.001
Heart rate 67 ± 11.6 65.4 ± 10.9 <0.001
Serum creatinine, mg/dl 0.9 ± 0.3 0.9 ± 0.2 <0.001
Physical activity score 9.8 ± 3.4 13.3 ± 5.2 0.67
Smoking, n (%) 525 (40.6) 584 (48.8) 0.17
Education, yr in school 12.1 ± 3.6 13.4 ± 2.3 <0.001
Alcohol intake, oz/month 1.5 ± 5.5 5.6 ± 10.5 <0.001
Previous history of MI or stroke 152 (11.8) 129 (10.8) 0.24
Statin use, n (%) 242 (18.7) 346 (28.9) <0.001
Aspirin, n (%) 430 (33.3) 490 (40.9) <0.001
Diuretic use, n (%) 605 (47) 452 (35) <0.001
β-Blockers, n (%) 221 (17) 393 (33) <0.001
RAAS blockers, n (%) 517 (40) 422 (35) <0.001
Ca-channel blockers, n (%) 371 (29) 178 (15) <0.001
Copeptin (pmol/liter) 8.0 (5.0–12.7) 5.0 (3.3–7.9) <0.001

Continuous variables are presented as means ± sd or median and interquartile range, whereas categorical variables are presented as counts and percentages. MI, Myocardial infarction; RAAS, renin-angiotensin-aldosterone system; Ca-channel, calcium channel. 

a

P values for variables age and men are unadjusted. All other variables are adjusted for age and sex.